Faes Farma, officially known as Faes Farma S.A., is a prominent pharmaceutical company headquartered in Spain. Established in 1933, the company has evolved into a key player in the healthcare industry, focusing on the development, manufacturing, and marketing of innovative pharmaceutical products. With a strong presence in Europe and Latin America, Faes Farma is dedicated to therapeutic areas such as central nervous system disorders, respiratory diseases, and dermatology. The company is recognised for its unique formulations and commitment to research and development, which have led to several notable achievements in the pharmaceutical sector. Faes Farma's extensive portfolio includes both prescription medications and over-the-counter products, positioning it as a trusted name in the market. With a rich history and a forward-thinking approach, Faes Farma continues to make significant contributions to global health.
How does Faes Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Faes Farma's score of 27 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Faes Farma reported total carbon emissions of approximately 7,280,000 kg CO2e, comprising 4,965,000 kg CO2e from Scope 1 and 2,615,000 kg CO2e from Scope 2 emissions. This reflects a notable increase from 2022, where emissions were about 4,268,000 kg CO2e, with Scope 1 contributing 3,782,000 kg CO2e and Scope 2 at 856,000 kg CO2e. In 2021, the company recorded emissions of approximately 5,042,000 kg CO2e, with Scope 1 at 3,874,000 kg CO2e and Scope 2 at 1,652,000 kg CO2e. Faes Farma has not disclosed any specific reduction targets or initiatives, nor does it appear to have cascaded data from a parent organization. The company has not reported on Scope 3 emissions, indicating a potential area for future focus. Overall, while Faes Farma has made strides in tracking its emissions, further commitments and transparency regarding climate initiatives would enhance its sustainability profile.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 3,874,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,652,000 | 000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Faes Farma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.